Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy
Q Long, P Zheng, X Zheng, W Li, L Hua, Z Yang… - Advanced drug delivery …, 2022 - Elsevier
Bacterial membrane vesicles (BMVs) have emerged as novel and promising platforms for
the development of vaccines and immunotherapeutic strategies against infectious and …
the development of vaccines and immunotherapeutic strategies against infectious and …
[HTML][HTML] Peptide-based vaccines for tuberculosis
W Gong, C Pan, P Cheng, J Wang, G Zhao… - Frontiers in …, 2022 - frontiersin.org
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. As a
result of the coronavirus disease 2019 (COVID-19) pandemic, the global TB mortality rate in …
result of the coronavirus disease 2019 (COVID-19) pandemic, the global TB mortality rate in …
[HTML][HTML] Biological nanoparticles in vaccine development
SM Curley, D Putnam - Frontiers in Bioengineering and …, 2022 - frontiersin.org
Vaccines represent one of the most successful public health initiatives worldwide. However,
despite the vast number of highly effective vaccines, some infectious diseases still do not …
despite the vast number of highly effective vaccines, some infectious diseases still do not …
[HTML][HTML] Prophylactic vaccine delivery systems against epidemic infectious diseases
C Pan, H Yue, L Zhu, G Ma, H Wang - Advanced drug delivery reviews, 2021 - Elsevier
Prophylactic vaccines have evolved from traditional whole-cell vaccines to safer subunit
vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and …
vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and …
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer
Research on bacterial membrane vesicles (BMVs) is an emerging topic, and the goal is to
address whether BMVs can bring translational tools to improve current therapies. In this …
address whether BMVs can bring translational tools to improve current therapies. In this …
[HTML][HTML] Engineered remolding and application of bacterial membrane vesicles
L Qiao, Y Rao, K Zhu, X Rao, R Zhou - Frontiers in Microbiology, 2021 - frontiersin.org
Bacterial membrane vesicles (MVs) are produced by both Gram-positive and Gram-negative
bacteria during growth in vitro and in vivo. MVs are nanoscale vesicular structures with …
bacteria during growth in vitro and in vivo. MVs are nanoscale vesicular structures with …
[HTML][HTML] Yersinia enterocolitica-Derived Outer Membrane Vesicles Inhibit Initial Stage of Biofilm Formation
G Ma, Y Ding, Q Wu, J Zhang, M Liu, Z Wang, Z Wang… - Microorganisms, 2022 - mdpi.com
Yersinia enterocolitica (Y. enterocolitica) is an important food-borne and zoonotic pathogen.
It can form biofilm on the surface of food, increasing the risk to food safety. Generally, outer …
It can form biofilm on the surface of food, increasing the risk to food safety. Generally, outer …
Outer membrane vesicles displaying a heterologous PcrV-HitA fusion antigen promote protection against pulmonary Pseudomonas aeruginosa infection
Along with surging threats and antibiotic resistance of Pseudomonas aeruginosa in health
care settings, it is imperative to develop effective vaccines against P. aeruginosa infection. In …
care settings, it is imperative to develop effective vaccines against P. aeruginosa infection. In …
[HTML][HTML] Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis
D Hau, B Wade, C Lovejoy, SG Pandit… - PLOS Neglected …, 2022 - journals.plos.org
Background Yersinia pestis is the causative agent of plague, a zoonosis associated with
small mammals. Plague is a severe disease, especially in the pneumonic and septicemic …
small mammals. Plague is a severe disease, especially in the pneumonic and septicemic …
Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection
To develop an effective Pseudomonas aeruginosa outer-membrane-vesicle (OMV) vaccine,
we eliminated multiple virulence factors from a wild-type (WT) P. aeruginosa strain, PA103 …
we eliminated multiple virulence factors from a wild-type (WT) P. aeruginosa strain, PA103 …